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Synthesis of endothiopeptides by using the 'azirine/oxazolone
method'
Abstract
The reaction of tert-butyl- or THP-protected mandelic thioacid (7a and 7b) with
N,N,2,2-tetramethyl-2H-azirin-3-amine (2a) gave the dipeptide analogues tBu- and
THP-Mns-Aiby[CS]NMe2 (8a and 8b, resp.) with a C-terminal thioamide group. Treatment of 8a with
HCl gas in toluene led to 2-(1-tert-butoxybenzyl)-4,4-dimethyl-1,3-thiazole-5(4H)-one (9), which
reacted with dimethylamine via ring opening to give tBu-Mnsy[CSNH]Aib-NMe2 (11a), an isomer of
8a with the thioamide group within the chain, i.e., the product of a sulfur migration. In the case of 8b,
selective deprotection of the THP-hydroxy group was achieved by treatment with pyridinium
p-toluenesulfonate (PPTS) in ethanol. Cyclization of the resulting Mns-Aiby[CS]NMe2 (13) yielded the
2-thioxomorpholin-5-one 10. In a similar manner, Boc-Val-SH (14) reacted with azirine 2b to give
Boc-Val-Aiby[CS]N(Me)Ph (15a), which was transformed to Fmoc-Val-Aiby[CS]N(Me)Ph (15b) and
further to Fmoc-Valy[CSNH]Aib-N(Me)Ph (16) by treatment with ZnCl2 in acetic acid. Coupling of
two of these molecules via the 1,3-thiazol-5(4H)-one 17 yielded the endodithiopeptide
Fmoc-Valy[CSNH]Aib-Valy[CSNH]Aib-N(Me)Ph (19).
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The re ac tion of tert-butyl- or THP-pro tected mandelic thioacid (7a and 7b) with
N,N,2,2-tetramethyl-2H-azirin-3-amine (2a) gave the di pep tide an a logues tBu- and
THP-Mns-Aiby[CS]NMe2 (8a and 8b, resp.) with a C-ter mi nal thio amide group. Treat -
ment of 8a with HCl gas in to lu ene led to 2-(1-tert-butoxy benzyl)-4,4- dimethyl-1,3-
 thiazole-5(4H)-one (9), which re acted with dimethylamine via ring open ing to give
tBu-Mnsy[CSNH]Aib-NMe2 (11a), an iso mer of 8a with the thio amide group within the
chain, i.e., the prod uct of a sul fur mi gra tion. In the case of 8b, se lec tive deprotection of
the THP-hydroxy group was achieved by treat ment with pyridinium p-toluenesulfonate
(PPTS) in eth a nol. Cyclization of the re sult ing Mns-Aiby[CS]NMe2 (13) yielded the
2-thioxomorpholin-5-one 10. In a sim i lar man ner, Boc-Val-SH (14) re acted with
azirine 2b to give Boc-Val-Aiby[CS]N(Me)Ph (15a), which was trans formed to Fmoc-
 Val-Aiby[CS]N(Me)Ph (15b) and fur ther to Fmoc-Valy[CSNH]Aib-N(Me)Ph (16) by
treat ment with ZnCl2 in ace tic acid. Cou pling of two of these mol e cules via the
1,3-thiazol-5(4H)-one 17 yielded the endodithiopeptide Fmoc- Valy[CSNH]Aib-
 Valy[CSNH]Aib-N(Me)Ph (19).
Key words: endothiopeptides, peptide synthesis, 2H-azirin-3-amines, a-amino iso -
butyric acid
Pep tide an a logues with a mod i fied pep tide back bone are of cur rent in ter est [1]
be cause of their bi o log i cal [2] and struc tural prop er ties [3]. Two such mod i fi ca tions
are the re place ment of pro tein amino ac ids by a,a-disubstituted α-amino ac ids
[3a,b][4,5] and the in tro duc tion of thio amide bonds [2f–h] (see also refs. cited in [6]). 
With a mod i fi ca tion of the so-called ‘azirine/oxazolone method’, we have de vel oped
a pro to col for the in tro duc tion of 2-aminoisobutyric acid (Aib) and a thio amide group 
into pep tides [6–8].
Endothiopeptides are pep tides con tain ing one or sev eral thio amide groups in
their back bone [9]. One of their bi o log i cal fea tures is the slower hy dro ly sis com pared 
with the par ent pep tides [2,10] but also di verse phar ma co log i cally at trac tive prop er -
ties [11]. One of the first syn the ses of an endothiopeptide, i.e., the re ac tion of
Z-glycine thiono ethylester with glycine un der ba sic con di tions, was pub lished in
1961 [12]. A fre quently used method for the prep a ra tion of endothiodipeptides is the
Pol ish J. Chem., 83, 195–206 (2009)
* Parts of the Diploma theses of A. B. and B. B., University of Zürich; presented at the VIIIth  Polish
Symposium on the Organic Chemistry, £ódŸ, Poland, April 2008.
thionation with Lawesson re agent [13], but fur ther seg ment cou pling at the C-ter mi nus
is dif fi cult and of ten leads to the for ma tion of the cor re spond ing 1,3- thiazol-
 5(4H)-one and ex ten sive epimerization. Fur ther more, regioselective thionations of
glycine in tripeptides have been re ported [14] as well as a se ries of thioacylation re ac -
tions with a-amino thioacids [15], a-amino thionoesters [16], a-amino dithioesters
[17], and dif fer ent ac ti vated a-amino thionoacid de riv a tives [18]. In a very re cent pa -
per it has been shown that endothiopeptides can be con ve niently ob tained via the Ugi
re ac tion us ing thio ac ids [19].
The bases for the use of the ‘azirine/oxazolone method’ [7] in the syn the sis of
endothiopeptides are the fol low ing re ac tions [8] (Scheme 1): 1. N-pro tected a-amino 
thioacids 1 re act with 2H-azirin-3-amines 2 at room tem per a ture to give di pep tide
thio amides 3; 2. acid cat a lyzed cyclization yields 1,3-oxazole-5(4H)-thiones 4,
which spon ta ne ously re ar range to give 1,3-thiazol-5(4H)-ones 5; 3. nucleophilic ring 
open ing leads to the endothiopeptide 6*. It was also shown that the isomerization 3 ®
6 can be per formed un der wa ter-free con di tions by treat ment with ZnCl2/AcOH fol -
lowed by HCl/AcOH [8]. This im proved pro to col was suc cess fully used for the prep -
a ra tion of an endothiodecapeptide as an an a logue of the C-ter mi nal decapeptide of
the peptaibol zervamicin IIA [8a]**.
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Scheme 1
*   The selectivity of the acidic hydrolysis (last step with NuH = H2O) is often low and loss of sulfur as well as
  cleavage of the backbone was observed.
** In another example, a secondary cyclization of the endothiopeptide leading to a peptide containing a
 1,3-thiazol-5(4H)-imine unit occurred [8d,f].
In the pres ent pa per, we de scribe the syn the ses of an endodithiotetrapeptide and
an endothiodipeptide an a logue of mandelic thioacid and a-aminoisobutyric acid
(Aib).
RE SULTS AND DIS CUS SION
With the aim of ex tend ing the scope of the re ac tions pre sented in Scheme 1, we
car ried out the re ac tion of O-pro tected racemic mandelic thioacid 7 with N,N,2,2-
 tetra methyl-2H-azirin-3-amine (2a). The start ing ma te rial 7a was pre pared from the
known benzyl mandelate [20] by treat ment with iso bu tene and conc. H2SO4 in di -
chloro methane, fol lowed by hydrogenolytic cleav age of the benzyl es ter in eth a nol
with Pd/C as the cat a lyst. The ob tained carboxylic acid was trans formed into thioacid 
7a by sub se quent treat ment with N,N¢-carbonyldiimidazole (CDI) and H2S in aceto -
nitrile. The re ac tion of the crude 7a with 2a in acetonitrile oc curred at room tem per a -
ture to give the ter mi nal thio amide 8a as a col or less solid in high yield.
The struc ture of 8a was de ter mined on the ba sis of the spec tro scopic data and el e -
men tal anal y ses. Char ac ter is tic data are the IR ab sorp tions (CHCl3) at 1660 and 1490
cm–1 for the am ide and thio amide group, re spec tively, and the cor re spond ing sig nals
in the 13C-NMR spec trum (CDCl3) at 169.8 and 205.0 ppm. The 1H- and 13C-NMR
sig nals for PhCH and Me2N ab sorb at 4.86/74.7 ppm and 3.34/45.4 ppm, and the
methyl groups of Me2C ap pear as one sig nal at 1.75 ppm in the 1H- and as two sig nals
at 27.2 and 26.7 ppm in the 13C-NMR spec trum.
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Scheme 2
In a sim i lar man ner, the crude THP-pro tected mandelic thioacid 7b, which was
pre pared from mandelic acid in acetonitrile in a one-pot re ac tion by sub se quent treat -
ment with 3,4-dihydro-2H-pyrane and HCl, fol lowed by CDI and H2S, re acted with
2a to give 8b (Scheme 3).
The cyclization of  8a was car ried out in to lu ene at 90°C. A vig or ous stream of dry 
HCl gas was bub bled through the sus pen sion for 30 min. Af ter chro mato graphic
workup, the ma jor prod uct (60%) was iden ti fied as the 1,3-thiazol-5(4H)-one 9*. An
in tense IR ab sorp tion  (CHCl3) at 1710 cm–1 and sig nals in the 13C-NMR spec trum at
210.9 and 170.4 ppm for C(5) and C(4), re spec tively, are in dic a tive. As a mi nor prod -
uct (6%), the 2-thioxomorpholin-5-one 10 was ob tained**. Ob vi ously, the Boc group
was not per fectly sta ble un der the acidic re ac tion con di tions, what al lowed the
cyclization via the OH group (see be low).
Treat ment of a so lu tion of 9 in dry di chloro methane with gas eous dimethylamine
at 0°C led to 11a (Scheme 2), the endothio-iso mer of 8a, which, af ter chro mato -
graphic workup, was ob tained in 92% yield. The same prod uct was formed when a
stream of HCl gas was bub bled through a so lu tion of 8a in dry to lu ene at 80°C, fol -
lowed, af ter cool ing to 0°C, by dry dimethylamine gas. The one-pot isomerization 8a
® 11a, a for mal intramolecular sul fur trans fer re ac tion, gave 11a in 53% yield***.
The anal o gous re ac tion of 9 in meth a nol with a cat a lytic amount of po tas sium
tert-butanolate at room tem per a ture led to the methylester 11b (Scheme 2).
With the aim of isomerizing the THP-pro tected 8b into the prod uct with an
‘endo-thio amide group’ anal o gous to 11a, a so lu tion of 8b in to lu ene at 80°C was
treated with HCl gas. But, in stead of the cor re spond ing 1,3-thiazol-5(4H)-one, only
the deprotected hydroxy com pound 12 could be de tected in low yield (Scheme 3).
This re sult shows that the THP group was not sta ble un der the cho sen con di tions, in
con trast to pre vi ously re ported re sults [23].
The se lec tive deprotection of the OH group with out sul fur mi gra tion was
achieved by treat ment of a so lu tion of 8b in eth a nol with pyridinium p-toluene -
sulfonate (PPTS) to give 13 in 90% yield. The re ac tion of 13 in to lu ene at 90°C with
HCl gas led, af ter chro mato graphic workup, to a sin gle prod uct lack ing a di -
methylamino group in mod est yield. On the ba sis of its IR and NMR data, the crys tal -
line prod uct with a m.p. 103.7–107.4°C was as signed the struc ture of the
2-thioxo morpholin-5-one 10 (Scheme 3). The char ac ter is tic sig nals in the 1H-NMR
spec trum (CDCl3) are singlets of PhCH and Me2C at 6.39 and 1.36/1.32 ppm, re spec -
tively. The cor re spond ing 13C-ab sorp tions ap pear at 65.0 and 23.8/23.6 ppm; ad di -
tional sig nals at 210.4, 191.5, and 69.8 ppm be long to C=S, C=O, and Me2C,
re spec tively. In the 1H,13C-cou pled 13C-NMR spec trum, the C=S sig nal ap peared as
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*     The same product 9 was obtained in 79% yield after treatment of 8a in chloroform with trimethylsilyl
     iodide at room temperature (cf. [21]).
**    For the preparation of similar morpholine derivatives, see [22].
***    The reaction of 11a with p-toluenesulfonic acid monohydrate in toluene at room temperature yielded
    again the 1,3-thiazol-5(4H)-one 9 (79%).
a heptuplet with J = 4.2 Hz, whereas the C=O sig nal was a broad sin glet. These data
ex clude the struc ture of the iso meric 3,3-dimethyl-6- phenyl-5- thioxo mor -
pholin-2-one.
With the aim of pre par ing Aib-con tain ing endothiopeptides with more than one
thio amide group in the pep tide back bone, we syn the sized the endothiopeptide
Fmoc-Valy[CSNH]Aib-N(Me)Ph (16) and planned to cou ple two of these mol e cules
af ter proper deprotection. Fol low ing a known pro to col [8b], Boc-Val-OH was trans -
formed into Boc-Val-SH (14) via the mixed an hy dride with isobutyl chloroformate
and sub se quent treat ment with H2S, which was gen er ated in situ. The crude prod uct
was dis solved in di chloro methane and re acted with N,2,2-trimethyl-N- phenyl-2H-
 azirin-3-amine (2b) at 0°C to room tem per a ture to give the di pep tide Boc-
 Val-Aiby[CS]N(Me)Ph (15a) with a C-ter mi nal thio amide group (Scheme 4). Then,
the Boc pro tect ing group was re placed by the Fmoc group, and the re sult ing 15b was
treated sub se quently with ZnCl2 in ace tic acid and HCl in ace tic acid to give the
endothiodipeptide Fmoc-Valy[CSNH]Aib-N(Me)Ph (16).
The two iso meric thiodipeptides 15b and 16 show sig nif i cant dif fer ences in the
NMR spec tra (CDCl3). For ex am ple, the MeN sig nal ap pears in the 1H- and
13C-NMR spec tra at 3.71/51.3 ppm and 3.26/41.0 ppm, re spec tively. In ad di tion, the
C=S and the two C=O groups show 13C shifts of 208.3/168.7/156.1 and
201.0/171.7/155.8 ppm, re spec tively (see also [8b]). Fur ther more, the chem i cal
shifts of the NH groups are in dic a tive: whereas NH of Val ap pears in both cases as a
dou blet at 5.45 and 5.78 ppm, re spec tively, with J = 8.0 and 8.3 Hz, the NH of Aib of
15b ab sorbs be tween 7.78 and 7.16 ppm to gether with the ar o matic H-at oms and that
of 16 ap pears as a sin glet at 8.15 ppm.
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Treat ment of 16 in di chloro methane with cam phor-10-sulfonic acid (CSA) at
room tem per a ture gave the 1,3-thiazol-5(4H)-one 17 in 86% yield as a col or less
solid. An other part of 16 was deprotected at the N-ter mi nus by the re ac tion with
dimethylamine in di chloro methane lead ing to 18 in 89% yield. Fi nally, 17 and 18
were cou pled in acetonitrile in the pres ence of 1-hydroxybenzotriazole (HOBt) and
ethyl(diisopropyl)amine (DIEA) at room tem per a ture. This re ac tion pro ceeded very
slowly, and af ter 14 days, the de sired endodithiotetrapeptide Fmoc- Valy -
[CSNH]Aib-Valy[CSNH]Aib-N(Me)Ph (19) was ob tained in only 21% yield.
The struc ture of 19 was es tab lished by spec tro scopic meth ods. The ESI-MS
showed [M+Na]+ at m/z 752. The as sign ment of the NMR sig nals of the pep tide back -
bone was pos si ble by us ing 1H, 13C, DEPT 135, HSQC, and HMBC spec tra in
CD3OD with a few drops of deuterated trifluoroacetic acid (TFA). Un der these con di -
tions, a slow de com po si tion of 19 was ob served, which oc curs, most likely, via
cyclization to give 1,3-thiazol-5(4H)-ones and elim i na tion of N-methylaniline or
cleav age of the pep tide chain.
CON CLU SIONS
The re ac tion of thioacids with 2,2-dimethyl-2H-azirin-3-amines has been car ried 
out with OH-pro tected mandelic thioacid and Boc-Val-SH to give the dipeptides with 
a C-ter mi nal thio amide group in ex cel lent yield. Acid-cat a lyzed isomerization of the
lat ter yielded the cor re spond ing endothiodipeptides via an in ter me di ate 1,3-thia -
zole-5(4H)-one. The com bi na tion of these two re ac tions, which has been called
‘mod i fied azirine/oxazolone method’ [8b], is a con ve nient and ef fi cient ap proach to
endothiodipeptides con tain ing Aib. The cou pling of the lat ter via the cor re spond ing
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Scheme 4
1,3-thiazol-5(4H)-one with a sec ond endothiodipeptide led to the endo dithio tetra -
peptide, how ever in low yield. Nev er the less, this method of fers an at trac tive ap -
proach to pep tides with al ter nat ing am ide and thio amide groups, which should be
fur ther de vel oped.
EX PER I MEN TAL
1. Ab bre vi a tions. Aib, 2-aminoisobutyric acid (2-methylalanine); CDI, N,N¢-carbonyldiimidazole;
HOBt, 1-hydroxy-1H-benzotriazole; i-BuOCOCl, isobutyl carbonochloridate; NMM, N-methyl mor -
pholine.
2. Gen eral. See [7d][24]. M.p.’s were de ter mined on a Mett ler-FP-5 or Büchi B-450 ap pa ra tus; un -
cor rected. IR spectra: Perkin-Elmer-297 or Perkin-Elmer-1600-FT-IR spectrophotometer; in cm–1.
1H-NMR spectra: Varian EM-390 or Bruker-ARX-300 in stru ment (90 and 300 MHz, resp.); 13C-NMR
spec tra: Bruker-AM-400 or Bruker-ARX-300 in stru ment (100.6 and 75.5 MHz, resp.); HSQC and HMBC
spec tra: Bruker-DRX-600 in stru ment (600 and 150.9 MHz, resp.), in CDCl3; TMS as an in ter nal stan dard,
mul ti plic ity of C-at oms from DEPT spec tra. MS: Varian MAT-112S (EI, 70 eV) or Finnigan MAT
SSQ-700 in stru ment (ESI); m/z (rel.%). El e men tal anal y ses were per formed by the Mikroanalytisches
Labora torium des Organisch-chemischen Instituts der Universität Zürich.
3. Start ing ma te ri als. (±)-Mandelic acid (Mns), Boc-L-valine (Boc-Val-OH), (±)-cam phor-
 10-sulfonic acid (CAS), 9-(9H-fluorenyl)methyl chloroformate (Fmoc-Cl), isobutyl chloroformate
(i-BuCO2Cl), 1-hydroxy-1H-benzotriazole (HOBt), and N,N¢-carbonyldiimidazole (CDI) are com mer cial 
prod ucts (Fluka). N,N,2,2-Tetramethyl-2H-azirin-3-amine (2a) [25] and N,2,2-trimethyl- N-phenyl- 2H-
 azirin-3-amine (2b) [26] were syn the sized ac cord ing to known pro ce dures. All other chem i cals and sol -
vents used were pur chased from Fluka.
4. Syn the sis of thioacids. 4.1. THP-Mandelic thioacid (THP-Mns-SH, 7b). To a stirred so lu tion of
mandelic acid (7.5 g, 49.3 mmol) in abs. acetonitrile (35 ml) at 0°C was added 3,4-dihydro-2H-pyrane (4.8
g, 57 mmol) and a 2M so lu tion of HCl in acetonitrile (1 ml). Af ter 3 h at room tem per a ture, the so lu tion was
cooled to 0°C and CDI (8.9 g, 55 mmol) added. The re sult ing so lu tion was added to a vig or ously stirred sat u -
rated so lu tion of H2S in dry pyridine (50 ml) while H2S (freshly pre pared from FeS and HCl) was bub bled
through the mix ture (see [27]). Af ter blowing H2S through the mix ture for 2.5 h, the so lu tion was again
cooled to 0°C, acid i fied by ad di tion of H2SO4 (50% aq. so lu tion), and ex tracted with Et2O. The com bined
Et2O phase was washed with 2M HCl, dried over MgSO4, and the sol vent evap o rated: 12.6 g (quant.) of
crude 7b. Yel low oil. IR (CHCl3): 2935s, 2865m, 2565w, 1694s, 1118s, 1021s, 968s, 908m. 1H-NMR
(CDCl3): 7.65–7.20 (m, 5 arom. H); 5.30–5.15 (m, 0.5 H); 5.05–4.80 (m, 1 H); 4.75–4.55 (m, 0.5 H);
4.15–3.30 (m, CH2); 2.10–1.50 (m,  3 CH2).
4.2. O-(Tert-butyl)mandelic thioacid (tBu-Mns-SH, 7a). To a so lu tion of benzyl mandelate [20]
(18.14 g, 74.9 mmol) in di chloro methane (100 ml) was added conc. H2SO4 (1 ml). Then, iso bu tene was
bub bled through the so lu tion at 15°C, the so lu tion was stirred for 30 h at room tem per a ture, and iso bu tene
was blown through again. Af ter 4 d stand ing at room tem per a ture, chro mato graphic workup (SiO2, hex -
ane/AcOEt 8:1) gave 14.5 g (65%) benzyl O-(tert-butyl)mandelate, which was dis solved in eth a nol (150
ml) and treated with H2 in the pres ence of Pd/C for 4 h. Af ter usual workup, 10.1 g (quant.) of
O-(tert-butyl)mandelic acid were ob tained. Col or less oil. IR (CHCl3): 3340m, 2950s, 1767s, 1726s,
1621s, 1451m, 1392m, 1368s, 1175m, 1071m. 1H-NMR (CDCl3): 8.40 (br. s, COOH); 7.60–7.20 (m, 5
arom. H); 5.07 (s PhCH); 1.26 (s, Me3C). CI-MS: 209 [M+1]+. This ma te rial (9.74 g, 46.8 mmol) was
trans formed into the cor re spond ing thioacid ac cord ing to the pro ce dure de scribed in sec tion 4.1 (8.5 g,
52.4 mmol CDI): 9.92 g (94.5%) of crude 7a, which was used in the next re ac tion with out pu ri fi ca tion.
5. Re ac tion of thioacids with 2H-azirin-3-amines 2. 5.1. O-(tert-Butyl)-N-[1- (dimethyl thio -
carbamoyl)-1-methylethyl]mandelamide (tBu-Mns-Aiby[CS]NMe2, 8a). To a so lu tion of crude 7a (9.92
g, 42.1 mmol) in acetonitrile (65 ml) at 0°C was added 2a (4.47 g, 39.9 mmol). Af ter stir ring at room tem -
per a ture for 40 min, chro mato graphic workup (SiO2, AcOEt/hex ane 5:2) gave 11.7 g (87% with re spect to
2a) of 8a. Col or less solid, m.p. 112.4–118.6°C. IR (CHCl3): 3385w, 3210w, 2980m, 1660s, 1490s,
1451m, 1370s, 1136m. 1H-NMR (CDCl3): 8.56 (br. s, NH); 7.70–7.20 (m, 5 arom. H); 4.86 (s, PhCH);
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3.34 (s, Me2N); 1.75 (s, Me2C); 1.27 (s, Me3C). 13C-NMR (CDCl3): 205.0 (s, C=S); 169.8 (s, C=O); 139.7
(s, 1 arom. C); 127.6, 127.4, 127.3, 127.0, 125.9 (5d, 5 arom. CH); 75.8 (s, Me3CO); 74.7 (d, PhCH); 60.0
(s, Me2C); 45.4 (br. s, Me2N); 27.8 (q, Me3C); 27.2, 26.7 (2q, Me2C). EI-MS: 336 (2, M+·), 248 (32), 192
(18), 173 (38), 163 (18), 146 (23), 130 (17), 108 (10), 107 (100), 105 (11), 90 (12), 88 (22), 85 (10), 79
(13), 77 (14). Anal. Calcd for C18H28N2O2S (336.49): C 64.25, H 8.39, N 8.32, S 9.53; found: C 64.04, H
8.21, N 8.27, S 9.31.
5.2. N-[1-(Dimethylthiocarbamoyl)-1-methylethyl]-O-(tetrahydropyran-2-yl)mandelamide
(THP-Mns-Aibψ[CS]NMe2, 8b). To a so lu tion of crude 7b (3.59 g, 14.2 mmol) in acetonitrile (40 ml) at
0°C was added 2a un til 7b was com pletely con sumed (TLC, 1.80 g, 16.05 mmol 2a). Af ter stir ring at room 
tem per a ture over night, chro mato graphic workup (SiO2, AcOEt/hex ane 4:1) yielded 4.5 g (87% with re -
spect to 7b) of 8b. Col or less solid, m.p. 130.1–136.7°C. IR (CHCl3): 3400w, 3200w, 2935m, 1662s,
1492s, 1376m, 1133m, 1120m, 1030m, 969m. 1H-NMR (CDCl3)*: 9.06, 8.79 (2s, NH); 7.65–7.25 (m, 5
arom. H); 5.10 (s, PhCH); 4.90, 4.59 (2t, J = 8 Hz, 1 H of THP); 4.00–3.30 (m, CH2 of THP); 3.40 (s,
Me2N); 2.00–1.40 (m, Me2C, 3 CH2 of THP). 13C-NMR (CDCl3)*: 205.1, 205.0 (2s, C=S); 168.3, 167.9
(2s, C=O); 137.8, 137.0 (2s, 1 arom. C); 128.1, 127.9, 127.8, 127.4, 126.9, 126.4, 126.2, 126.0 (8d, 5
arom. CH); 97.4, 95.9 (2d, CH of THP); 78.0, 77.5 (2d, PhCH); 62.2, 61.7 (2t, CH2 of THP); 60.1, 59.9
(2s, Me2C); 45.5 (br. s, Me2N); 30.1 (t, CH2 of THP); 27.8, 26.9, 26.0, 24.9 (2q, 2t, Me2C, CH2 of THP);
18.9, 18.5 (2t, CH2 of THP). EI-MS: 364 (0.2, M+·), 276 (9), 192 (42), 173 (9), 146 (22), 130 (5), 107 (6),
105 (7), 90 (8), 88 (10), 85 (100), 84 (10), 79 (7), 77 (9).
5.3. Boc-Val-Aiby[CS]N(Me)Ph (15a). To a so lu tion of Boc-Val-OH (5.00 g, 23.0 mmol) in abs.
THF (50 ml) at –10°C were added N-methylmorpholine (NMM, 5.2 ml, 47.2 mmol) and i-BuCO2Cl (3.8
ml, 29.0 mmol). Af ter stir ring for 5 min at –10°C, a vig or ous stream of H2S (gen er ated from Na2S and
H2SO4, 50%) was bub bled through the sus pen sion for 4 h. Then, Et2O was added, the so lu tion washed
with 0.1M H3PO4 so lu tion (3´), and the com bined org. phase was dried over MgSO4. Evap o ra tion of the
sol vent gave ca. 6 g of crude Boc-Val-SH as a yel low oil. The lat ter was dis solved in CH2Cl2 (100 ml) and
cooled to 0°C. Then, 2b (3.6 ml, 24.8 mmol) was added and the so lu tion stirred at room tem per a ture for 15
h. The mix ture was washed with NaHSO4 so lu tion (5%), the organic phase was dried over MgSO4, fil -
tered, and the sol vent evap o rated. The re sult ing yel low ish pow der was sus pended in hex ane, the solid
washed with hex ane and dried in high vac uum to give 8.3 g (88%) of 15a [8b]. Yel low ish pow der, m.p.
148.0–149.7°C. IR (KBr): 3379m, 3335m, 3268m, 2969m, 2931m, 1687s, 1670m, 1646s, 1537m, 1518m,
1492m, 1466m, 1432m, 1385m, 1367s, 1293m, 1253m, 1166m, 1102s, 1074m. 1H-NMR (CDCl3):
7.45–7.18 (m, 5 arom. H); 7.08 (br. s, NH); 5.12 (br. d, J ca. 8 Hz, NH); 3.76–3.65 (m, HCa(Val)); 3.71 (s,
MeN); 2.11–2.00 (m, HCb(Val)); 1.64, 1.57 (2s, Me2C);  1.47 (s, Me3C); 0.92, 0.85 (2d, J = 6.8 Hz, 2 Me of 
Val). 13C-NMR (CDCl3): 208.4 (s, C=S(Aib)); 169.3 (s, C=O(Val)); 155.6 (C=O(ure thane)); 147.2 (s, 1
arom. C); 129.5, 128.4, 126.3 (3d, 5 arom. CH); 79.4 (s, Me3C); 62.6 (s, Me2C); 59.5 (d, Ca(Val)); 51.0 (q,
MeN); 31.3 (d, Cβ(Val)); 28.9, 28.7 (2q, Me2C); 28.2 (q, Me3C); 19.1, 17.3 (2q, 2 Me of Val).
5.4. Fmoc-Val-Aibψ[CS]N(Me)Ph (15b). A so lu tion of 15a (2.19 g, 5.37 mmol) in 3M HCl
(THF/H2O 1:1, 70 ml) was stirred for 20 h at room tem per a ture and then cooled to 0°C. Af ter ad di tion of
Na2CO3 un til pH 9 was reached, H2O and dioxane (60 ml each) and Fmoc-Cl (1.46 g, 5.63 mmol) were
added, and the mix ture stirred for 20 h at room tem per a ture. The mix ture was ex tracted with Et2O, the
com bined org. phase was dried over MgSO4, and the sol vent evap o rated. Chro mato graphic workup gave
2.50 g (88%) of 15b [8b]. Yel low ish pow der, decomp. at 93°C. IR (KBr): 3407m, 3314m, 3064m, 2962m,
2929m, 2868m, 1720s, 1713s, 1665s, 1594m, 1493s, 1464s, 1451s, 1369s, 1320m, 1285m, 1233m,
1188m, 1168m, 1102s, 1028m, 1005m. 1H-NMR (CDCl3): 7.78–7.16 (m, 13 arom. H); 5.45 (br. d, J = 8.0
Hz, NH); 4.42 (br. d, J = 7.0 Hz, CHCH2O); 4.25 (t, J = 7.0 Hz, CHCH2O); 3.82–3.78 (m, HCa(Val)); 3.71
(s, MeN); 2.13–2.03 (m, HCb(Val)); 1.64, 1.56 (2s, Me2C); 0.93, 0.88 (2d, J = 6.7 Hz, 2 Me of Val).
13C-NMR (CDCl3): 208.3 (s, C=S(Aib)); 168.7 (s, C=O(Val)); 156.1 (C=O(ure thane)); 147.1, 143.8,
141.2 (3s, 5 arom. C); 129.5, 128.5, 127.6, 127.0, 126.3, 125.0, 119.9 (7d, 13 arom. CH); 66.9 (t,
CHCH2O); 62.8 (s, Me2C); 60.1 (d, Ca(Val)); 51.3 (q, MeN); 47.2 (d, CHCH2O); 31.6 (d, Cb(Val)); 28.7,
28.4 (2q, Me2C); 19.0, 17.5 (2q, 2 Me of Val).
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* Two conformers are present.
6. Acid-cat a lyzed re ac tions of thio amides 8a, 8b, and 15b. 6.1. Re ac tions of 8a. 6.1.1. For ma tion of
O-(tert-butyl)-N-[1-(dimethylcarbamoyl)-1-methylethyl]mandelthioamide (tBu-Mnsy[CSNH]Aib- NMe2,
11a). A sus pen sion of 8a (1.12 g, 3.33 mmol) in dry to lu ene (50 ml) was heated to 80°C, and a vig or ous
stream of dry HCl gas was bub bled through the mix ture for 2 min. Then, the mix ture was stirred while N2
was blown through for 10 min, the mix ture cooled to 0°C, dry dimethylamine bub bled through, and the
mix ture stirred at room tem per a ture in a closed round bot tom flask. The mix ture was fil tered through a
SiO2 col umn and eluted with Et2O and then chromatographically pu ri fied (SiO2, Et2O/pentane 19:1),
yield ing 598 mg (53%) of 11a. This ma te rial has to be kept dis solved in Et2O at 5°C. IR (CHCl3): 3305w,
3210w, 2920s, 2855m, 1627s, 1491m, 1452m, 1391m, 1368m, 1170m, 1110m, 1045m, 1016m. 1H-NMR
(CDCl3): 9.46 (br. s, NH); 7.70–7.20 (m, 5 arom. H); 5.28 (s, PhCH); 2.81 (s, Me2N); 1.77, 1.71 (2s,
Me2C); 1.25 (s, Me3C). 13C-NMR (CDCl3): 200.0 (s, C=S); 171.3 (s, C=O); 140.4 (s, 1 arom. C); 127.6,
127.4, 127.3, 127.2, 126.2 (5d, 5 arom. CH); 81.8 (d, PhCH); 76.4 (s, Me3CO); 59.5 (s, Me2C); 37.2 (br. s,
Me2N); 28.0 (q, Me3C); 23.9, 23.4 (2q, Me2C). EI-MS: 336 (0.5, M+·), 174 (10), 173 (100), 115 (10), 114
(46), 108 (8), 107 (60), 100 (21), 86 (15), 79 (8), 77 (6).
The same prod uct 11a was ob tained when dry dimethylamine was bub bled through a stirred so lu tion of
1,3-thiazol-5(4H)-one 9 (125 mg, 0.43 mmol) in CH2Cl2 (9 ml) for 1 h at 0°C. Chro mato graphic workup
gave 133 mg (92%) of 11a.
6.1.2. For ma tion of 2-[1-(tert-butoxy)benzyl]-4,4-dimethyl-1,3-thiazol-5(4H)-one (9). A sus pen -
sion of 8a (720 mg, 2.14 mmol) in dry to lu ene (300 ml) was heated to 90°C and a vig or ous stream of dry
HCl gas bub bled through it for 30 min. Then, N2 was blown through the sus pen sion for 30 min, while it
was cooled to room tem per a ture. The sol vent was evap o rated, the res i due dis solved in THF, and Et2O
added to pre cip i tate salts. Fil tra tion, evap o ra tion of the sol vent, and chro mato graphic sep a ra tion (SiO2,
pen tane/Et2O 4:1) gave 374 mg (60%) of 9 and 31 mg (6%) of 3,3-dimethyl- 6-phenyl- 2-thio xo mor -
pholin-5-one (10). Data of 9: Yel low crys tals, m.p. 37.3–40.5°C. IR (CHCl3): 2925m, 2815m, 1710s,
1618m, 1487w, 1450m, 1391m, 1368m, 1135m, 1085m, 991m, 894m. 1H-NMR (CDCl3): 7.60–7.25 (m, 5
arom. H); 5.46 (s, PhCH); 1.42, 1.31 (2s, Me2C); 1.31 (s, Me3C). 13C-NMR (CDCl3): 210.9 (s, C(5));
170.4 (s, C(2)); 138.8 (s, 1 arom. C); 128.1, 127.7, 125.7 (3d, 5 arom. CH); 82.4 (s, Me2C); 76.3 (s,
Me3CO); 75.2 (d, PhCH); 28.0 (q, Me3C); 23.8 (q, Me2C). EI-MS: 234 (1, [M–Me3C]+), 163 (31), 108 (8),
107 (100), 100 (8), 79 (8), 77 (7). Anal. Calcd for C16H21NO2S (291.41): C 65.95, H 7.26, N 4.81, S 11.00;
found: C 65.97, H 7.22, N 4.68, S 11.03.
The 1,3-thiazol-5(4H)-one 9 was also ob tained from 11a: A so lu tion of 11a (216 mg, 0.64 mmol) in to lu -
ene (35 ml), sat u rated with p-toluenesulfonic acid monohydrate was stirred at room tem per a ture for 4 h.
The mix ture was fil tered through a short SiO2 col umn with Et2O as the sol vent. Chro mato graphic pu ri fi -
ca tion (SiO2, pentane/Et2O 3:1) gave 148 mg (79%) of 9.
In an other ex per i ment, to a so lu tion of 11a (233 mg, 0.69 mmol) in dry CHCl3 (10 ml) at room tem per a ture 
was added re peat edly trimethylsilyliodide (4 drops). Af ter evap o ra tion of the sol vent, the res i due was
treated with Et2O, fil tered, and the fil trate pu ri fied by chro ma tog ra phy (SiO2, pentane/Et2O 4:1): 161 mg
(80%) of 9.
6.1.3. For ma tion of  O-(tert-butyl)-N-[1-(methoxycarbonyl)-1-methylethyl]mandelthioamide (11b).
To a so lu tion of  9 (125 mg, 0.43 mmol) in ab so lute meth a nol (8 ml) at room tem per a ture was added a small 
amount of tBuOK. Af ter 10 min, the mix ture was fil tered, the fil trate evap o rated, and the res i due
chromatographically pu ri fied (SiO2, pentane/Et2O 4:1), yield ing 131 mg (94%) of 11b as a col or less oil.
IR (CHCl3): 3340w, 3285w, 2983m, 2960w, 1740s, 1510s, 1456s, 1409m, 1396m, 1381m, 1372m, 1283s,
1161s, 1054m, 1026m. 1H-NMR (CDCl3): 9.10 (br. s, NH); 7.60–7.20 (m, 5 arom. H); 5.24 (s, PhCH);
3.67 (s, MeO); 1.73 (s, Me2C); 1.28 (s, Me3C). EI-MS: 323 (2, M+·), 163 (20), 108 (11), 107 (100), 102
(13), 101 (12), 100 (12), 79 (23), 77 (15).
6.2. Re ac tions of  8b. 6.2.1. At tempted isomerization with HCl. Treat ment of a sus pen sion of 8b in
dry to lu ene at 80°C with dry HCl gas ac cord ing to 6.1.1 led to ex ten sive de com po si tion and only traces of
a prod uct, which is pro posed to be N-[1-(dimethylcarbamoyl)-1-methylethyl]mandelthioamide (12) were 
ob tained.
6.2.2. Deprotection to give N-[1-(dimethylthiocarbamoyl)-1-methylethyl]mandelamide
(Mns-Aiby[CS]NMe2, 13). A so lu tion of 8b (1.92 g, 5.27 mmol) and pyridinium p-toluenesulfonate (133
mg) in eth a nol (95%, 90 ml) was heated to re flux for 15 h. Chro mato graphic workup yielded 1.33 g (90%)
of 13. Col or less solid, m.p. 122.2–124.6°C. IR (CHCl3): 3400w, 3285w, 2990w, 2940w, 1670m, 1500s,
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1379m, 1139m. 1H-NMR (CDCl3): 8.23 (s, NH); 7.50–7.20 (m, 5 arom. H); 4.97 (s, PhCH); 4.20 (br. s,
OH); 3.32 (s, Me2N); 1.72, 1.68 (2s, Me2C). EI-MS: 280 (2, M+·), 192 (30), 173 (8), 119 (11), 107 (22),
105 (8), 88 (12), 86 (18), 85 (10), 84 (23), 79 (14), 77 (18), 69 (54), 58 (100). Anal. Calcd for
C14H20N2O2S (280.23): C 60.00, H 7.19, N 10.00, S 11.44; found: C 59.80, H 7.41, N 9.85, S 11.33.
6.2.3. For ma tion of 3,3-dimethyl-6-phenyl-2-thioxomorpholin-5-one (10). A sus pen sion of 13 (253
mg, 0.90 mmol) in dry to lu ene (110 ml) at 90°C was treated with a stream of dry HCl gas for 15 min. Af ter
bub bling N2 through the mix ture un til room tem per a ture was reached, the sol vent was evap o rated, and the
res i due dis solved in CH2Cl2. Ad di tion of THF and Et2O led to the for ma tion of a pre cip i tate, which was
fil tered. Evaporation of the fil trate and chro mato graphic sep a ra tion (SiO2, Et2O/pentane 2:1) gave 64 mg
(30%) of 10. Col or less solid, m.p. 103.7–107.4°C. IR (CHCl3): 3290w, 2970w, 2930w, 1692s, 1597m,
1446m, 1326m, 1311m, 1110m, 1002m, 950m, 860m. 1H-NMR (CDCl3): 8.10–7.90 (m, 2 arom. H);
7.70–7.40 (m, 3 arom. H); 6.39 (s, PhCH); 1.36, 1.32 (2s, Me2C). 13C-NMR (CDCl3): 210.4 (s, C=S);
191.5 (s, C=O); 134.4 (s, 1 arom. C); 133.8, 128.9, 128.3 (3d, 5 arom. CH); 69.8 (s, Me2C); 65.0 (d,
PhCH); 23.8, 23.6 (2q, Me2C). 13C-NMR (100.6 MHz, CDCl3, non-de coup led): 210.7 (hept, J = 4.2);
191.7 (br. s). EI-MS: 207 (28), 175 (17), 160 (50), 130 (46), 105 (29), 102 (100), 77 (37), 70 (36), 58 (50).
6.3. Re ac tions of 15b. 6.3.1. For ma tion of Fmoc-Valy[CSNH]Aib-N(Me)Ph (16). A so lu tion of 15b
(0.42 g, 0.79 mmol) and ZnCl2 (1.3 g, 9.54 mmol) in ace tic acid (3 ml) was stirred for 20 min at room tem -
per a ture. Af ter ad di tion of  2.1 M HCl in ace tic acid, stir ring was con tin ued for 20 min at room tem per a -
ture, then, the pH was ad justed to 8 by ad di tion of a so lu tion of Na2CO3 (5%), the mix ture ex tracted with
CH2Cl2, the com bined or ganic phase was dried over MgSO4, fil tered, and the sol vent evap o rated. Chro -
mato graphic workup (SiO2, hex ane/AcOEt/CH2Cl2 2:2:1) gave 0.28 g (68%) of 16 [8b]. Col or less solid,
m.p. 132.0–133.1°C. IR (KBr): 3383m, 3212m, 3052m, 2960m, 2929m, 2890m, 2868m, 1728s, 1631s,
1593m, 1562m, 1500s, 1450m, 1429m, 1395m, 1375m, 1362m, 1304m, 1261m, 1244m, 1213m, 1182m,
1168m, 1124m, 1095m, 1068m, 1038m. 1H-NMR (CDCl3): 8.15 (br. s, NH); 7.78–7.22 (m, 13 arom. H);
5.78 (br. d, J = 8.3 Hz, NH); 4.46–4.39 (m, CHCH2O); 4.25 (t, J = 7.0 Hz, CHCH2O); 3.92–3.81 (m,
HCa(Val)); 3.26 (s, MeN); 2.19–2.04 (m, HCb(Val)); 1.71, 1.63 (2s, Me2C); 0.93, 0.90 (2d, J = 6.7 Hz, 2
Me of Val). 13C-NMR (CDCl3): 201.0 (s, C=S(Val)); 171.7 (s, C=O(Aib)); 155.8 (C=O(ure thane)); 143.7, 
141.2 (2s, 5 arom. C); 129.3, 128.2, 127.9, 127.6, 127.0, 125.0, 119.9 (7d, 13 arom. CH); 67.0 (t,
CHCH2O); 66.9 (s, Me2C); 61.9 (d, Ca(Val)); 47.1 (d, CHCH2O); 41.0 (q, MeN); 34.0 (d, Cb(Val)); 25.1,
23.7 (2q, Me2C); 19.5, 17.9 (2q, 2 Me of Val).
6.3.2. For ma tion of 2-[1-(Fmoc-amino)-2-methylpropyl]-4,4-dimethyl-1,3-thiazol-5(4H)-one (17). 
To a so lu tion of 16 (0.32 g, 0.60 mmol) in CH2Cl2 (7.5 ml) was added CSA (0.15 g, 0.66 mmol) and the
mix ture stirred for 90 s at room tem per a ture. Then, a so lu tion of NaHCO3 (5%) was added, the mix ture ex -
tracted with CH2Cl2, the com bined or ganic phase was dried over MgSO4, fil tered, and the sol vent evap o -
rated. Chro mato graphic workup (SiO2, hex ane/AcOEt 6:1) gave 0.22 g (86%) of 17. Col or less solid, m.p.
95.2–96.6°C. IR (KBr): 3413m, 3225w, 2973m, 2932m, 2885m, 1728s, 1622m, 1502s, 1466m, 1448m,
1390m, 1380m, 1370m, 1346m, 1328m, 1303m, 1262m, 1249m, 1220m, 1202m, 1155m, 1098m, 1066m,
1032m, 989m, 963m, 935m, 923m, 861m, 813m. 1H-NMR (CDCl3): 7.78–7.26 (m, 8 arom. H); 5.39 (br. d,
J = 8.4 Hz, NH); 4.67–4.56 (m, CHCH2O); 4.56–4.39 (m, CHCH2O); 4.25 (t, J = 6.8 Hz, HCa(Val));
2.30–2.12 (m, HCb(Val)); 1.42, 1.40 (2s, Me2C); 1.05, 0.93 (2d, J = 6.7 Hz, 2 Me of Val). 13C-NMR
(CDCl3): 209.4 (s, C(5)); 164.4 (s, C(2)); 155.0 (C=O(ure thane)); 142.9, 142.7, 140.4 (3s, 4 arom. C);
126.7, 126.1, 124.1, 124.0, 119.0 (5d, 8 arom. CH); 82.1 (s, Me2C); 66.0 (t, CHCH2O); 59.0 (d, Ca(Val));
46.3 (d, CHCH2O); 30.4 (d, Cb(Val)); 23.6, 23.3 (2q, Me2C); 18.3, 15.7 (2q, 2 Me of Val).
6.3.3. For ma tion of H2N-Valy[CSNH]Aib-N(Me)Ph (18). To a so lu tion of 16 (0.44 g, 0.84 mmol) in
CH2Cl2 (15 ml) was added dimethylamine (1.5 ml) and the mix ture stirred for 18 h at room tem per a ture.
Evap o ra tion of the sol vent and chro mato graphic workup (SiO2, hex ane/AcOEt/CH2Cl2 2:2:1) gave 0.23
g (89%) of 18 as a col or less oil. IR (KBr): 3413w, 3343w, 3156m, 2966m, 2933m, 2903m, 1817m, 1794m,
1640vs, 1594s, 1493s, 1465s, 1388s, 1310m, 1288m, 1269m, 1247m, 1172m, 1096s, 985m, 902vs, 754vs.
1H-NMR (CDCl3): 9.41 (br. s, NH); 7.50–7.25 (m, 5 arom. H); 4.16 (br. d, J = 7.9 Hz, NH); 3.62 (br. s,
NH); 3.35 (br. s, HCa(Val)); 3.25 (s, MeN); 2.63–2.51 (m, HCb(Val)); 1.80, 1.64 (2s, Me2C); 0.95, 0.65
(2d, J = 6.8 Hz, 2 Me of Val). 13C-NMR (CDCl3): 201.7 (s, C=S); 171.2 (s, C=O); 128.8 (s, 1 arom. C);
128.1, 127.6, 127.2 (3d, 5 arom. CH); 68.4 (d, Ca(Val)); 62.9 (s, Me2C); 41.0 (q, MeN); 32.3 (d, Cb(Val));
25.0, 23.6 (2q, Me2C); 20.3, 15.2 (2q, 2 Me of Val).
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7. Syn the sis of Fmoc-Valy[CSNH]Aib-Valy[CSNH]Aib-N(Me)Ph (19). A so lu tion of 18  (0.18 g,
0.58 mmol), 17 (0.36 g, 0.85 mmol), HOBt (0.20 g, 1.30 mmol), and ethyl(diisopropyl)amine (0.15 ml,
0.87 mmol) in acetonitrile (5 ml) was stirred for 14 d at room tem per a ture. The white pre cip i tate formed
was fil tered ev ery sec ond day, washed with hex ane, and dried in high vac uum: 88 mg (21%) of 19. Col or -
less pow der, decomp. >200°C. IR (KBr): 3407w, 3307w, 3220s, 3049m, 2966m, 2933w, 2870w, 1724s,
1655s, 1633s, 1594w, 1551m, 1523s, 1496s, 1451m, 1414s, 1386m, 1362m, 1299m, 1233m, 1206s,
1092m, 1030m, 760m, 741m, 709m. 1H-NMR (CD3OD/d-TFA): 7.81–7.28 (m, 13 arom. H); 4.37 (d-like,
CHCH2O); 4.34 (d-like, HCa(Val2)); 4.21 (t-like, CHCH2O); 3.98 (d, J = 9.3 Hz, HCa(Val1)); 3.09 (s,
MeN); 2.17–1.91 (m, HCb(Val1+2)); 1.71, 1.55 (2s, Me2C(Aib1)); 1.32, 1.30 (2s, Me2C(Aib2)); 1.05, 0.92
(2d, J = 6.5 Hz, 2 Me of Val1); 0.84, 0.78 (2d, J = 6.6 Hz, 2 Me of Val2). 13C-NMR (150 MHz,
CD3OD/d-TFA): 212.0 (s, C=S(Val2)); 206.7 (s, C=S(Val1)); 175.6 (s, C=O(Aib1)); 167.8 (s,
C=O(Aib2)); 158.9 (s, C=O(ure thane)); 145.3, 145.2, 142.7, 142.6 (4s, 5 arom. C); 131.7, 131.1, 128.9,
128.8, 128.3, 128.2, 126.6, 126.3, 123.1, 121.0, 120.9, 117.9, 115.6 (13d, 13 arom. CH); 84.2 (s,
Me2C(Aib2)); 69.1 (d, Ca(Val1)); 68.3 (t, CHCH2O); 61.8 (s, d, Me2C(Aib1, Ca(Val2)); 48.4 (d,
CHCH2O); 37.9 (q, MeN); 33.9 (d, Cb(Val1)); 31.4 (d, Cb(Val2));  28.2, 21.9 (2q, Me2C(Aib1)); 24.7, 24.6
(2q, Me2C(Aib1));  19.9, 19.7 (2q, 2 Me of Val2); 19.8, 19.6 (2q, 2 Me of Val1). ESI-MS: 752 (100,
[M+Na]+), 623 (18), 423 (69), 201 (13).
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